$LLY 1 post

• What happens next following FDA approval of Mounjaro® from Eli Lilly for diabetes?
  22 May 2022  ·  $LLY $NVO diabetes
  The FDA on May 13th approved the dual GIP-GLP1-agonist Mounjaro ® (tirzepatide) from Eli Lilly for diabetes following the completion of the SURPASS studies (e.g. SURPASS-2 NCT03987919 ).